Are drug-eluting stents living up to the hype?

July 2005    Volume 12, Issue 2   Br J Cardiol (Acute Interv) Cardiol 2005;12:AIC 42–AIC 44

Authors:
Adrian P Banning

Drug-eluting stents (DES) have been available commercially in the UK for over three years. The National Institute for Clinical Excellence (NICE) produced a technology appraisal in October 2003 and that initial review is about to be updated. Well, has this technology delivered on its promise? Have we embraced it too quickly or is 100% DES usage around the corner?

back to top

Comments

There are currently no comments for this article - leave a comment

You must be logged in to post a comment.
Not yet a member? Register now for free.

back to top